Journal-Based CME: First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant

Journal-Based CME: First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant is organized by Memorial Sloan Kettering Cancer Center (MSKCC).

Start Date: October 31, 2023
End Date: October 31, 2026

Description:
This Journal-Based CME activity consists of a full-text article that is free to read, a multiple-choice question test, and an evaluation/self-assessment. Learners are tested on their comprehension of the key concepts, with the objective of enriching their clinical practice and patient care through better understanding of scientific advances and new techniques in the fields covered by Journal of Experimental Medicine (JEM).

Questions for this complimentary, online-only activity have been designed by JEM editors in collaboration with the article authors. Each CME activity should take approximately 1 hour to complete.

The article selected for this activity is First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant by Esther Bernaldo-de-Quirós, Rafael Correa-Rocha, and colleagues at the Instituto de Investigación Sanitaria Gregorio Marañón in Madrid, Spain.